Detalles de la búsqueda
1.
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial.
Blood
; 121(16): 3284-8, 2013 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-23435461
2.
Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trial.
Haematologica
; 100(7): 964-9, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25840597
3.
Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial.
Lancet Oncol
; 15(7): 757-66, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24827808
4.
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial.
Blood
; 130(12): 1477-1480, 2017 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28716861
5.
Impact of telomere length on the outcome of allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial.
Br J Haematol
; 179(2): 342-346, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27391907
6.
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial.
Blood
; 116(14): 2438-47, 2010 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-20595516
7.
Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8+ cytotoxic T cells.
Haematologica
; 102(11): e460-e464, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28838995
8.
Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial.
Haematologica
; 101(12): e485-e487, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27540135
9.
Cutaneous gamma/delta T-cell lymphoma.
J Dtsch Dermatol Ges
; 7(12): 1065-7, 2009 Dec.
Artículo
en Inglés, Alemán
| MEDLINE | ID: mdl-19694889
10.
M-phase phosphoprotein 11 is a highly immunogenic tumor antigen in patients with acute myeloid leukemia.
Acta Haematol
; 127(4): 193-7, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22433847
11.
Survivin-derived peptide epitopes and their role for induction of antitumor immunity in hematological malignancies.
Leuk Lymphoma
; 47(6): 978-85, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16840186
12.
Contemporary definitions of tumor specific antigens, immunogens and markers as related to the adaptive responses of the cancer-bearing host.
Anticancer Res
; 25(3c): 2345-55, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16080461
13.
High expression of the immature laminin receptor protein correlates with mutated IGVH status and predicts a favorable prognosis in chronic lymphocytic leukemia.
Leuk Res
; 35(6): 721-9, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21055809
14.
Vaccination against lymphoma.
Haematologica
; 90(1): 3, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15644302
15.
Humoral immune responses against the immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia.
J Immunol
; 180(9): 6374-84, 2008 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18424761
16.
Identification of HLA-A*0201-presented T cell epitopes derived from the oncofetal antigen-immature laminin receptor protein in patients with hematological malignancies.
J Immunol
; 176(11): 6935-44, 2006 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16709854
17.
Induction of antitumour immunity using survivin peptide-pulsed dendritic cells in a murine lymphoma model.
Br J Haematol
; 122(6): 911-4, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12956760
18.
Therapeutic effects of idiotype vaccination can be enhanced by the combination of granulocyte-macrophage colony-stimulating factor and interleukin 2 in a myeloma model.
Br J Haematol
; 120(1): 27-35, 2003 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-12492573
19.
Enhanced antitumoral effectiveness of idiotype vaccination induced by the administration of Flt3 ligand combined with interleukin 2 against a murine myeloma.
Br J Haematol
; 117(1): 93-102, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11918538
20.
Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies.
Blood
; 102(13): 4416-23, 2003 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12869512